Medical Care
Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 438009
- Pages: 80
- Figures: 79
- Views: 2
The global Latent Tuberculosis Infection (LTBI) Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
By Type: (Dominant Segment vs High-Margin Innovation)
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Qiagen in Europe)
- Emerging Product Trends: Tuberculin Skin Test (TST) adoption vs. Interferon Gamma Released Assay (IGRA) premiumization
- Demand-Side Dynamics: Hospitals and Clinics growth in China vs. Diagnostic Laboratories potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Latent Tuberculosis Infection (LTBI) Testing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Interferon Gamma Released Assay (IGRA) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostic Laboratories in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Latent Tuberculosis Infection (LTBI) Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Market Segmentation
By Company:
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
By Type: (Dominant Segment vs High-Margin Innovation)
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Qiagen in Europe)
- Emerging Product Trends: Tuberculin Skin Test (TST) adoption vs. Interferon Gamma Released Assay (IGRA) premiumization
- Demand-Side Dynamics: Hospitals and Clinics growth in China vs. Diagnostic Laboratories potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Latent Tuberculosis Infection (LTBI) Testing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Interferon Gamma Released Assay (IGRA) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostic Laboratories in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Latent Tuberculosis Infection (LTBI) Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2020-2025)
2.4 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.6 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.7 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Latent Tuberculosis Infection (LTBI) Testing Representative Players
4 Breakdown Data by Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Latent Tuberculosis Infection (LTBI) Testing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2020-2025)
5.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
5.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Analysis
5.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
5.5 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head office and Area Served
5.6 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
5.7 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.1.2.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.1.3.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.2.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.2.3.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.3.2.2 China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.3.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.4.2.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.4.3.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.6.2.2 India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.6.3.2 India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Qiagen
7.1.1 Qiagen Company Details
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
7.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.1.5 Qiagen Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
7.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.2.5 Sanofi Recent Development
7.3 Oxford Immunotec
7.3.1 Oxford Immunotec Company Details
7.3.2 Oxford Immunotec Business Overview
7.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
7.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.3.5 Oxford Immunotec Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Details
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
7.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Par Sterile
7.5.1 Par Sterile Company Details
7.5.2 Par Sterile Business Overview
7.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
7.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.5.5 Par Sterile Recent Development
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Details
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
7.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.6.5 Bio-Rad Laboratories Recent Development
8 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
8.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
8.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
8.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
8.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Tuberculin Skin Test (TST)
1.2.3 Interferon Gamma Released Assay (IGRA)
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2020-2025)
2.4 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.6 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
2.5.7 Central & South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Type (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Latent Tuberculosis Infection (LTBI) Testing Representative Players
4 Breakdown Data by Application
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Historic Market Size by Application (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Latent Tuberculosis Infection (LTBI) Testing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Revenue (2020-2025)
5.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Latent Tuberculosis Infection (LTBI) Testing Revenue
5.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Analysis
5.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
5.5 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing Head office and Area Served
5.6 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
5.7 Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.1.2.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.1.3.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.2.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.2.3.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.3.2.2 China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.3.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.4.2.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.4.3.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.6.2.2 India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.6.3.2 India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Qiagen
7.1.1 Qiagen Company Details
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Introduction
7.1.4 Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.1.5 Qiagen Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Introduction
7.2.4 Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.2.5 Sanofi Recent Development
7.3 Oxford Immunotec
7.3.1 Oxford Immunotec Company Details
7.3.2 Oxford Immunotec Business Overview
7.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Introduction
7.3.4 Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.3.5 Oxford Immunotec Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Details
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Introduction
7.4.4 Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.4.5 Thermo Fisher Scientific Recent Development
7.5 Par Sterile
7.5.1 Par Sterile Company Details
7.5.2 Par Sterile Business Overview
7.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Introduction
7.5.4 Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.5.5 Par Sterile Recent Development
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Details
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Introduction
7.6.4 Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
7.6.5 Bio-Rad Laboratories Recent Development
8 Latent Tuberculosis Infection (LTBI) Testing Market Dynamics
8.1 Latent Tuberculosis Infection (LTBI) Testing Industry Trends
8.2 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
8.3 Latent Tuberculosis Infection (LTBI) Testing Market Challenges
8.4 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Region (2020-2025)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share Forecast by Region (2026-2031)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2020-2025)
Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2020-2025)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Latent Tuberculosis Infection (LTBI) Testing Application
Table 18. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2020-2025)
Table 20. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Table 21. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served
Table 24. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
Table 25. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 29. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 33. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 37. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 41. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 49. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 51. Qiagen Company Details
Table 52. Qiagen Business Overview
Table 53. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 54. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 55. Qiagen Recent Development
Table 56. Sanofi Company Details
Table 57. Sanofi Business Overview
Table 58. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 59. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Oxford Immunotec Company Details
Table 62. Oxford Immunotec Business Overview
Table 63. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 64. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 65. Oxford Immunotec Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 69. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Par Sterile Company Details
Table 72. Par Sterile Business Overview
Table 73. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 74. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 75. Par Sterile Recent Development
Table 76. Bio-Rad Laboratories Company Details
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 79. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Laboratories Recent Development
Table 81. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 82. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 83. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 84. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Product Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2024 VS 2031
Figure 3. Tuberculin Skin Test (TST) Features
Figure 4. Interferon Gamma Released Assay (IGRA) Features
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2024 VS 2031
Figure 6. Hospitals and Clinics
Figure 7. Diagnostic Laboratories
Figure 8. Others
Figure 9. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2024
Figure 21. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
Figure 23. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 24. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 25. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 26. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 27. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 28. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 29. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 30. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 31. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 32. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 33. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 34. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 35. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 36. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 37. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 39. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 40. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Region (2020-2025)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share Forecast by Region (2026-2031)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2020-2025)
Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2020-2025)
Table 15. Global Latent Tuberculosis Infection (LTBI) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Latent Tuberculosis Infection (LTBI) Testing Application
Table 18. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players (2020-2025)
Table 20. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Table 21. Ranking of Global Top Latent Tuberculosis Infection (LTBI) Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Headquarters and Area Served
Table 24. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Product and Application
Table 25. Global Key Players of Latent Tuberculosis Infection (LTBI) Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 29. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 33. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 37. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 41. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Latent Tuberculosis Infection (LTBI) Testing Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Company (2020-2025)
Table 49. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (US$ Million)
Table 51. Qiagen Company Details
Table 52. Qiagen Business Overview
Table 53. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product
Table 54. Qiagen Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 55. Qiagen Recent Development
Table 56. Sanofi Company Details
Table 57. Sanofi Business Overview
Table 58. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product
Table 59. Sanofi Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Oxford Immunotec Company Details
Table 62. Oxford Immunotec Business Overview
Table 63. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product
Table 64. Oxford Immunotec Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 65. Oxford Immunotec Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product
Table 69. Thermo Fisher Scientific Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Par Sterile Company Details
Table 72. Par Sterile Business Overview
Table 73. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product
Table 74. Par Sterile Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 75. Par Sterile Recent Development
Table 76. Bio-Rad Laboratories Company Details
Table 77. Bio-Rad Laboratories Business Overview
Table 78. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product
Table 79. Bio-Rad Laboratories Revenue in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Laboratories Recent Development
Table 81. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Table 82. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Table 83. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 84. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Product Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type: 2024 VS 2031
Figure 3. Tuberculin Skin Test (TST) Features
Figure 4. Interferon Gamma Released Assay (IGRA) Features
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application: 2024 VS 2031
Figure 6. Hospitals and Clinics
Figure 7. Diagnostic Laboratories
Figure 8. Others
Figure 9. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Central & South America Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Players in 2024
Figure 21. Global Top Latent Tuberculosis Infection (LTBI) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2024
Figure 23. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 24. North America Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 25. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 26. Europe Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 27. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 28. China Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 29. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 30. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 31. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 32. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 33. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Figure 34. India Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 35. Qiagen Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 36. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 37. Oxford Immunotec Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 38. Thermo Fisher Scientific Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 39. Par Sterile Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 40. Bio-Rad Laboratories Revenue Growth Rate in Latent Tuberculosis Infection (LTBI) Testing Business (2020-2025)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232